Summaries for patients. A comparison of medications used to prevent high-altitude pulmonary edema.
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000187:drug effects; D000328:Adult; D000532:Altitude Sickness / Q000503:physiopathology / Q000517:prevention & control*; D002243:Carbolines / Q000627:therapeutic use*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D003907:Dexamethasone / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000503:physiopathology / Q000517:prevention & control*; D000068581:Tadalafil; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D000068581:Tadalafil; D003907:Dexamethasone; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human